Updated:
Daehwa Pharm
Daehwa Pharm was established in 1984 by Kim Woon-jang and Soo-Ji Kim. The company operates as a corporate investor with headquarters in Gangwon-do, South...
Daehwa Pharm
Daehwa Pharm was established in 1984 by Kim Woon-jang and Soo-Ji Kim. The company operates as a corporate investor with headquarters in Gangwon-do, South Korea. Its investment activity spans early-stage seed and start-up rounds through expansion and late-stage deals. Confirmed holdings align with pharmaceutical and related technology areas. Geographic reach centers on South Korea with additional facilities in Gyeonggi-do. The firm employs staff across its GMP factory in Hoengseong and R&D center in Pangyo. It holds membership in the Korea Pharmaceutical and Bio-Pharma Manufacturers Association. Daehwa Pharm maintains direct ownership of operating assets including the Daehwa Building in Seoul and the Hyangnam API Plant.
General information
Firm type
Corporate Investor
Year founded
1984
AUM
151 (Altss estimate)
Location
Region
Asia
Country
South Korea
City
Gangwon-do
Corporate office
Gangwon-do, South Korea
Principals
Kim Woon-jang
Co-founder and Chairman
Soo-Ji Kim
Co-founder and Chairman
Eun-Seok Kim
Chief Executive Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Daehwa Pharm?
Eun-Seok Kim serves as Chief Executive Officer. Kim Woon-jang and Soo-Ji Kim act as co-founders and chairmen.
What investment stages does Daehwa Pharm target?
The firm covers early-stage seed and start-up rounds as well as expansion and late-stage opportunities.
Does Daehwa Pharm participate in fund commitments or only direct deals?
Activity centers on direct investments tied to its pharmaceutical and medical systems businesses.
Where does Daehwa Pharm maintain operations?
Headquarters sit in Gangwon-do with additional sites in Seoul, Hoengseong, Seongnam, and Hyangnam.
What industry association does Daehwa Pharm belong to?
It is an active member of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: